Gregory Glenn

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NVAX

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Novavax Inc (NVAX)	Former President, Research and Development	$593,750	—	$1,469,386	$1,861,216	$143,687	$25,647	$4,093,686
2021	Novavax Inc (NVAX)	Former President, Research and Development	$553,000	—	—	—	$226,730	$33,714	$813,444
2020	Novavax Inc (NVAX)	Former President, Research and Development	$483,443	—	$1,206,210	$22,859,741	$362,582	$11,400	$24,923,376
2019	Novavax Inc (NVAX)	President, Research and Development	$470,453	—	$348,306	$819,421	$225,818	$11,200	$1,875,198
2018	Novavax Inc (NVAX)	President, Research and Development	$460,125	—	—	$1,131,189	$79,142	$11,000	$1,681,456
2017	Novavax Inc (NVAX)	President, Research and Development	$450,000	—	—	$531,250	$229,500	$10,500	$1,221,250

No earnings-call appearances or filed executive changes recorded yet.